Recovered COVID-19 Patients’ Blood as Potential Treatment

According to the World Health Organization (WHO), there are currently 634,835 of confirmed coronavirus COVID-19 cases and 29,957 deaths in 202 countries. At this point, it’s not possible for any authority to claim that there will be a decrease in these numbers any time soon.

Despite the constant efforts of the governments of the countries affected by the deadly virus COVID-19 and despite being supported by the WHO, the world hasn’t reached the ultimate treatment for the disease just yet.

Recently, a research study was conducted on macaques that recovered of the coronavirus COVID-19 disease. The study showed that the monkeys have antibodies in their blood and, therefore, they’re now immune and are most unlikely to develop the infection again.

Based on this study, researchers suggested the idea that, since the majority of former COVID-19 patients are able to develop antibodies to fight the disease, and henceforth, they can’t develop infection of the COVID-19 for a second time, their blood can actually be the primary solution to treat new patients.

The therapy, a.k.a. convalescent plasma, is based on taking the plasma, which is the liquid portion of blood that does not include blood cells or platelets, from former patients and analyzing it.

The aim, here, is to find antibodies that the immune system built while the virus attacked the body. Not only do these antibodies fight the virus until it disappears, but they also provide an important level of protection, preventing the virus from attacking the body again in the future.

Researchers now want to take the antibodies drawn from the recovered people’s plasma and inject them in the new patients’ blood in order to strengthen their immune system and, hopefully, guarantee a quick recovery.

The testing of this idea will be soon conducted in New York. In fact, the Vaccine Research Center at the National Institutes of Health already put out a call looking for blood donations from former COVID-19 patients.

The whole procedure of convalescent plasma testing and application is a vein injection procedure that can be complexified by the invisibility of the patient’s vein, particularly if they are old, very young (babies), obese or simply having a skin condition that affects the visibility of their veins.

In these cases, vein finders are essential to make the whole process easier and safer, because repetitive needle insertion can be very painful and can cause damage to the veins.

SIFVEIN-7.2 vein detector uses a near-infrared technology that interacts with the blood color and illuminates the veins beneath the skin surface, making a visible vein map on the patient’s hand, arm, face, etc.

Portable Vein Finder SIFVEIN-7.2 has a good adjustable brightness that helps doctors and nurses to customize the image brightness based on the room’s light and the skin tone of the patient.

Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFVEINFINDER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each vein finder device.

The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.